Page 3 - Pharma Exports

Pharma companies can draw $30 bn revenue from US market by tapping 10 drugs

Despite having good demand from across the markets, primarily due to lower prices and easy availability, India controls only 2.4 per cent of global pharma exports

Q3 results preview: US regulatory overhang on earnings of pharma firms

The US is Indian pharma's largest export market and Indian drugmakers account for a little over 30 per cent of generic drugs sold in that country

Indian pharma exports hit $19.14 bn, report double-digit growth after 3 yrs

Indian pharma exports registered a double-digit growth of 10.17 per cent at $16.89 billion last time in 2015-16

State drug controllers get power to issue NOCs for drugs meant for export

BS ReporterHyderabad, 3 August: State drug controllers have been given complete jurisdiction to issue no objection certificates(NOCs) for manufacture of unapproved, banned or new drugs that are solely meant for exports. The Drug Control General of India (DCGI) discontinued the earlier practice wherein the grant of such NoCs were being overseen by the Central Drugs Standard Control Organisation(CDSCO). These orders will come into effect from August 20, 2018.The Pharmaceutical Export Promotion Council of India (Pharmexcil) has recently approached the drug regulator seeking a waiver of bio equivalence(BE) studies for grant of license of oral dosage form of drugs specified under BCS category 2 and 4 for export purpose.Drug controllers in some states were insisting on submission of results of BE studies endorsed by the CDSO for grant of license to manufacture such drugs for export purpose and this has been causing difficulties to the exporters, according to Pharmexcil. "In order to ...

Pharma exports see double digit growth after a gap of three years

In April, pharma exports to the US has grown by 17.47 per cent as compared to a 10 per cent decline in the same month last year

Lax industry norms, tough entry process slows pharma exports to China

Currently, pharma shipments make up only 0.3% of the total $13.33 billion exports to China

How the pharma growth story fizzled out

Pharma exports now seem to be losing their importance due to poor growth

Growth in Indian pharma exports revives in the third quarter

Hyderabad, 27 FebruaryIndian pharma exports have increased 5.6 per cent to $ 4,357 million during October-December period in this financial year over the same quarter previous fiscal, as per the Pharmaceuticals Export Promotion Council (Pharmexcil) data. The pharma body, which works under the Union Commerce Ministry, expects the rise in exports in the second half of this year to more than compensate for a marginal decline in the exports during April-October period.India has seen 9.7 per cent increase in pharma exports at $16.89 billion in the last financial year. The January-March quarter is likely to add further momentum to the export growth seen in the October-December period, according to Pharmexcil director general Ravi Uday Bhaskar. The country has 700 drug manufacturing units registered with the US Food and Drug Administration (USFDA). More than 30 per cent of abbreviated new drug applications (ANDAs) granted by the USFDA in 2016 are from India. This indicates an upward trend ..